Skip to main content

UBS Group AG

Position in RVTY — Revvity, Inc.

CIK 1610520 ZURICH, V8

Position in RVTY

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$118,762,011
-$40,336,783 QoQ
Shares Held
1,355,576
-17.6% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95.33548838279816.ToString("F0")% Shared 0.ToString("F0")% None 4.664511617201839.ToString("F0")%

Common Shares in RVTY Over Time

Shares Held

Position Value (USD)

Derivatives in RVTY

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$367,536
PutShares
3,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. RVTY ranks #13 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RVTY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $118,762,011 1,355,576
2025-12-31 $159,098,794 1,644,432
2025-09-30 $191,033,609 2,179,505
2025-06-30 $172,755,943 1,786,145
2025-06-30 $367,536 3,800
2025-03-31 $70,375,407 665,174
2024-12-31 $64,379,771 576,828
2024-09-30 $38,538,978 301,675
2024-06-30 $24,158,482 230,388
2024-03-31 $19,159,140 182,468
2023-12-31 $11,034,185 100,944
2023-09-30 $8,092,391 73,102
2023-06-30 $9,631,016 81,076
2023-03-31 $12,872,114 96,594
2022-12-31 $24,137,469 172,140
2022-09-30 $15,418,121 128,132
2022-06-30 $20,617,063 144,966
2022-03-31 $25,140,033 144,102
2021-12-31 $51,657,137 256,924
2021-09-30 $46,781,713 269,962
2021-06-30 $32,840,999 212,687
2021-03-31 $28,960,568 225,743
2020-12-31 $33,418,423 232,881
2020-09-30 $25,257,003 201,235
2020-06-30 $20,083,730 204,748
2020-03-31 $17,392,690 231,040